Abstract
Objective: Patients treated for childhood craniopharyngioma often develop hypothalamic obesity (HO), which has a huge impact on the physical condition and quality of life of these patients. Treatment for HO thus far has been disappointing, and although several different strategies have been attempted, all interventions had only transient effects. Since thyroid hormones increase energy expenditure metabolism (thyroid hormone induced thermogenesis), it was speculated that treatment with tri-iodothyronine (T3) may be beneficial. In 2002, a case report was published on reduction of body weight after T3 treatment for HO. No studies have been reported since. Recent experimental studies in rodents showed that T3 increases brown adipose tissue (BAT) activity via (pre)sympathetic pathways between the hypothalamus and BAT. Our aim was to investigate whether T3 treatment increases BAT activity in a patient with HO resulting from (treatment of) childhood craniopharyngioma.
Methods: Thyroxine treatment for central hypothyroidism was switched to T3 monotherapy. Serum T3 and free thyroxine (FT4) concentrations were measured twice weekly for 2 months. 123I-MIBG and 18F-FDG-PET after induction of non-shivering thermogenesis for the assessment of sympathetic and metabolic activity of BAT as well as indirect calorimetry for assessment of resting energy expenditure were performed before and during T3 treatment.
Results: No change in sympathetic and metabolic BAT activity, energy expenditure, or BMI was seen during T3 treatment despite the expected changes in thyroid hormone plasma concentrations.
Conclusion: We conclude that T3 monotherapy does not seem to be effective in decreasing HO in childhood craniopharyngioma.
References
1. Lustig RH. Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment. Front Endocrinol (Lausanne) 2011;2:60.10.3389/fendo.2011.00060Search in Google Scholar PubMed PubMed Central
2. Muller HL. Craniopharyngioma. Endocr Rev 2014;35:513–43.10.1210/er.2013-1115Search in Google Scholar PubMed
3. Muller HL. Childhood craniopharyngioma: treatment strategies and outcomes. Expert Rev Neurother 2014;14:187–97.10.1586/14737175.2014.875470Search in Google Scholar PubMed
4. Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, et al. Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2003;88:2586–92.10.1210/jc.2002-030003Search in Google Scholar PubMed
5. Muller HL. Paediatrics: surgical strategy and quality of life in craniopharyngioma. Nat Rev Endocrinol 2013;9:447–9.10.1038/nrendo.2013.125Search in Google Scholar PubMed
6. Bretault M, Boillot A, Muzard L, Poitou C, Oppert JM, et al. Clinical review: bariatric surgery following treatment for craniopharyngioma: a systematic review and individual-level data meta-analysis. J Clin Endocrinol Metab 2013;98:2239–46.10.1210/jc.2012-4184Search in Google Scholar PubMed
7. Fernandes JK, Klein MJ, Ater JL, Kuttesch JF, Vassilopoulou-Sellin R. Triiodothyronine supplementation for hypothalamic obesity. Metabolism 2002;51:1381–3.10.1053/meta.2002.35591Search in Google Scholar PubMed
8. Cannon B, Nedergaard J. Thyroid hormones: igniting brown fat via the brain. Nat Med 2010;16:965–7.10.1038/nm0910-965Search in Google Scholar PubMed
9. Lopez M, Varela L, Vazquez MJ, Rodriguez-Cuenca S, Gonzalez CR, et al. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med 2010;16:1001–8.10.1038/nm.2207Search in Google Scholar PubMed PubMed Central
10. Admiraal WM, Holleman F, Bahler L, Soeters MR, Hoekstra JB, et al. Combining 123I-metaiodobenzylguanidine SPECT/CT and 18F-FDG PET/CT for the assessment of brown adipose tissue activity in humans during cold exposure. J Nucl Med 2013;54:208–12.10.2967/jnumed.112.111849Search in Google Scholar PubMed
11. Lustig RH, Post SR, Srivannaboon K, Rose SR, Danish RK, et al. Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab 2003;88:611–6.10.1210/jc.2002-021180Search in Google Scholar PubMed
12. Lustig RH. Hypothalamic obesity: causes, consequences, treatment. Pediatr Endocrinol Rev 2008;6:220–7.Search in Google Scholar
13. Kalsbeek A, Bruinstroop E, Yi CX, Klieverik L, Liu J, et al. Hormonal control of metabolism by the hypothalamus-autonomic nervous system-liver axis. Front Horm Res 2014;42:1–28.10.1159/000358312Search in Google Scholar PubMed
14. Elowe-Gruau E, Beltrand J, Brauner R, Pinto G, Samara-Boustani D, et al. Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity. J Clin Endocrinol Metab 2013;98:2376–82.10.1210/jc.2012-3928Search in Google Scholar PubMed
15. Muller HL, Gebhardt U, Maroske J, Hanisch E. Long-term follow-up of morbidly obese patients with childhood craniopharyngioma after laparoscopic adjustable gastric banding (LAGB). Klin Padiatr 2011;223:372–3.10.1055/s-0031-1284420Search in Google Scholar PubMed
©2015 by De Gruyter
